Sintx Technologies (NASDAQ:SINT) Issues Earnings Results

Sintx Technologies (NASDAQ:SINT) released its quarterly earnings results on Friday. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04), FiscalAI reports. Sintx Technologies had a negative net margin of 1,018.08% and a negative return on equity of 242.76%. The business had revenue of $0.38 million during the quarter, compared to analysts’ expectations of $0.30 million.

Sintx Technologies Trading Down 5.4%

Shares of NASDAQ:SINT traded down $0.13 during trading on Friday, hitting $2.27. The stock had a trading volume of 30,165 shares, compared to its average volume of 40,487. Sintx Technologies has a 12-month low of $1.99 and a 12-month high of $6.78. The stock has a 50-day simple moving average of $2.57 and a two-hundred day simple moving average of $3.14.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC boosted its stake in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,624 shares of the company’s stock after acquiring an additional 9,265 shares during the quarter. Geode Capital Management LLC owned 0.72% of Sintx Technologies worth $103,000 at the end of the most recent reporting period. Institutional investors own 18.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Ascendiant Capital Markets decreased their price target on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. HC Wainwright began coverage on Sintx Technologies in a research note on Monday, April 13th. They issued a “buy” rating and a $10.00 price target for the company. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Sintx Technologies has a consensus rating of “Hold” and a consensus target price of $11.00.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.